Urinary angiotensin excretion during sodium restriction and diuretics

Area of Science:

• Renal Physiology
• Endocrinology
• Cardiovascular Regulation

Background:

• The renin-angiotensin-aldosterone system (RAAS) plays a crucial role in blood pressure regulation.
• Understanding the interplay between plasma and urinary angiotensin levels is vital for assessing RAAS activity.
• Factors like posture and sodium balance significantly influence RAAS components.

Purpose of the Study:

• To investigate the effects of posture and sodium intake on plasma and urinary angiotensin I and II, and plasma renin activity.
• To examine the impact of furosemide and chlorothiazide on these RAAS markers.
• To determine if urinary angiotensin excretion provides supplementary information to plasma measurements.

Main Methods:

• Measurements of urinary angiotensin I (UAI) and II (UAII), plasma angiotensin I (PAI) and II (PAII), and plasma renin activity (PRA) in seven healthy volunteers.
• Experimental conditions included supine and upright postures, free and restricted sodium intake.
• Inclusion of measurements before and after furosemide injection, and before and during chlorothiazide infusion.

Main Results:

• Upright posture and sodium restriction increased PAI, PAII, and PRA, but not UAI and UAII excretion.
• Furosemide increased all measured variables, with plasma angiotensins elevated less than PRA.
• Chlorothiazide reduced PAI, PAII, and PRA, while modestly increasing UAI and UAII excretion.

Conclusions:

• Changes in posture and sodium intake differentially affect plasma and urinary angiotensin levels.
• Diuretic administration impacts RAAS components, with varying effects on plasma versus urinary excretion.
• Urinary angiotensin excretion offers valuable, supplementary data to plasma measurements for comprehensive RAAS assessment.